Loading...

DMS Imaging SA

ASIT.BREURONEXT
Healthcare
Biotechnology
0.23
0.00(0.00%)

DMS Imaging SA (ASIT.BR) Company Profile & Overview

Explore DMS Imaging SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

DMS Imaging SA (ASIT.BR) Company Profile & Overview

DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium.

SectorHealthcare
IndustryBiotechnology
CEOThierry Legon

Contact Information

3222640390
7 Rue des Chasseurs Ardennais, Liege (Angleur), Liege, 4031

Company Facts

20 Employees
IPO DateMay 11, 2016
CountryBE

Frequently Asked Questions

;